Press Releases

Country Music Star Kellie Pickler to Perform at Roswell Park’s Celebration of Hope

BUFFALO, N.Y. — Country music star Kellie Pickler will perform at Roswell Park Comprehensive Cancer Center’s Celebration of Hope, a community-wide rally against cancer that will celebrate survivors, patients and all those who are fighting for a cure.

Friday, May 1, 2015 - 08:00 am

News

Roswell Park CEO is Featured Speaker at Networking Event Supporting Women in Science, Technology, Engineering & Math

Candace Johnson, PhD, President & CEO of Roswell Park Cancer Institute (RPCI), is the featured speaker at the Women in STEM Seminar and Networking event on Wednesday, May 6 from 7 to 9 pm in the Zebro Conference Room, Center for Genetics and Pharmacology, Roswell Park Cancer Institute, located at 670 Virginia Street, Buffalo, NY.

Friday, May 1, 2015 - 08:00 am

News

Frequent Aspirin Use Reduces Risk of Cervical Cancer by Nearly Half

Long-term and frequent use of aspirin is associated with significantly decreased risk of cervical cancer, according to a study led by researchers at Roswell Park Cancer Institute (RPCI) and published in the Journal of Lower Genital Tract Disease.

Thursday, April 30, 2015 - 08:00 am

News

University at Buffalo and Roswell Park Establish Dental Residency Program

Roswell Park Comprehensive Cancer Center and the University at Buffalo have been granted accreditation by the Commission on Dental Accreditation for a newly created general-practice dental residency program. Students in the one-year program will rotate between the UB Dental and Roswell Park Dental Services.

Wednesday, April 29, 2015 - 08:00 am

News

Roswell Park Faculty Members Offer Expert Commentary on Immunotherapy Research

Targeted immunotherapy offers promise for metastatic cervical cancer, according to Kunle Odunsi, MD, PhD, Cancer Center Deputy Director, Executive Director of the Center for Immunotherapy, and Chair of the Department of Gynecologic Oncology at Roswell Park Cancer Institute.

Wednesday, April 29, 2015 - 08:00 am

News

Camptothecin Analog FL118 Can Overcome Treatment Resistance, Outperform Approved Therapies

The latest research from the team that discovered the novel anticancer agent FL118 highlights distinctive characteristics of this small-molecule compound and provides insights into its ability to overcome the persistent problem of treatment resistance.

Tuesday, April 28, 2015 - 08:00 am

News

Cleveland BioLabs and Roswell Park Comprehensive Cancer Center Announce Award of Department of Defense Breast Cancer Research Program Breakthrough Grant for Entolimod

Cleveland BioLabs, Inc. and Roswell Park Cancer Institute today announced the award of a three-year, $1.2 million Breast Cancer Research Program Breakthrough Award to Roswell Park from the Department of Defense Congressionally Directed Medical Research Program for research into the immunotherapy of metastatic breast cancer with entolimod, a toll-like receptor 5 (TLR5) agonist.

Monday, April 27, 2015 - 08:00 am

News

Purposeful ‘Editing’ of RNA in Immune Cells May Be Linked to Viral Infections and Cancer

Researchers at Roswell Park Cancer Institute (RPCI) have made new findings about the causes and impacts of RNA modification or “editing.” Innate immune cells — the body’s first line of defense — possess the ability to extensively change genetic information by means of RNA modification as a response to factors associated with inflammation

Friday, April 24, 2015 - 08:00 am

News

TLR5 Genetic Variants May Predict Antitumor Responses to Entolimod

Roswell Park Cancer Institute (RPCI) researchers examined the characteristics of genetic variants in human toll-like receptor 5 (TLR5), and have found that these genetic variants may predict antitumor responses to entolimod, an immunotherapeutic agent with antitumor activity.

Wednesday, April 22, 2015 - 08:00 am